4-(6-Methyl-1,2,4,5-tetrazin-3-yl)benzoic acid

Overview

4-(6-Methyl-1,2,4,5-tetrazin-3-yl) benzoic acid is an asymmetric tetrazine derivative and a bioorthogonal reaction partner. 4-(6-Methyl-1,2,4,5-tetrazin-3-yl) benzoic acid can be conjugated with Bevacizumab ( HY-P9906 ) via EDC/NHS activation while retaining the VEGF -binding affinity of the antibody, thus constructing a targeting agent for pretargeted immuno-PET/NIRF imaging.

Application

Products | Products > Disease Areas > Others | Products > Signaling Pathways > Others | Products > Research Areas > Others | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-W422109
• CAS No.: 1345866-66-1
• Molecular Formula: C10H8N4O2
• Molecular Weight: 216.20
• Storage: Store at room temperature 3 years. In solvent -80°C, 2 years , -20°C, 1 year
• Availability: In-stock

Source

Original product source